Andreas Halvorsen acquired 6.42 Million Biomarin Pharmaceutical - Registered Shares shares worth $511 Million. That's 1.94% of their equity portfolio (19th largest holding). The investor owns 3.29% of the outstanding Biomarin Pharmaceutical - Registered Shares stock. The first Biomarin Pharmaceutical - Registered Shares trade was made in Q1 2016. Since then Andreas Halvorsen bought shares seventeen more times and sold shares on nine occasions. The investor's estimated purchase price is $555 Million, resulting in a loss of 7.9%.